Omeprazol Aurobindo (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Aurobindo, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton‑pump inhibitor that acts on gastric acid secretion pathways.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced gastropathy: reduces risk of ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Clostridioides difficile infection - Severe allergic reactions (e.g., anaphylaxis, angioedema) - Low magnesium (hypomagnesemia) with long‑term use. - Fracture risk   - Vitamin B12 deficiency   - Acute interstitial nephritis.

Omeprazole may require   

-   

t   t ​  lank \\